2025 Expert Speaker Faculty

Lola Fashoyin-Aje, FDA

‘Lola Fashoyin-Aje

Director, Office of Clinical Evaluation- cell, tissue, gene therapies

FDA

Amanda Placone, Eli Lilly

Amanda Placone

Senior Director External Innovation and Early Commercial Strategy

Eli Lilly

Amanda Rohrig, BridgeBio Gene Therapy

Amanda Rohrig (Virtual)

Director - Patient Advocacy

BridgeBio Gene Therapy

Amber freed

CEO & Founder

SLC6A1 Connect

Anjulika Chawla, bluebird bio

Anjulika Chawla

Vice President, Medical Affairs, Clinical Lead

bluebird bio

Yasuhiro Kishioka, PMDA

Atsushi Nishikawa

Principal Reviewer

PMDA

Brian Kevany, Abeona Therapeutics

Brian Kevany

Senior Vice President, Chief Technical & Scientific Officer

Abeona Therapeutics

Costanza Gorini, Beacon

Costanza Gorini

Senior Researcher, Beacon Research Operations

Beacon

Craig Malzahn, REGENXBIO

Craig Malzahn

Senior Vice President, Technical Operations

REGENXBIO

Daniel Chung, SparingVision

Daniel Chung

Chief Medical Officer

SparingVision

Delphine Agathon, Pfizer

Delphine Agathon

Category Clinician, Senior Director

Pfizer

Elizabeth Leshen, Novartis

Elizabeth Leshen

Head Of Safety, Efficiency, Gene Therapy & Rare Disease

Novartis

Francesca Cook

Vice President, Global Pricing & Market Access

REGENXBIO

Gail Ryan, Point32Health

Gail Ryan

Director - Pharmaceutical Transformation

Point32Health

Howard Wu, Full Circles Therapeutics

Howard Wu

Co-founder & Chief Scientific Officer

Full Circles Therapeutics

Jean - Philippe, Vivet Therapeutics

Jean-Phillippe Combal

Co-Founder & Chief Executive Officer

Vivet Therapeutics

Jie Li, Vertex Pharmaceuticals

Jie Li

Director

Vertex Pharmaceuticals

Kathleen Kirby, Merlin Therapeutics

Kathleen Kirby

Chief Operating Officer

Merlin Therapeutics

Kumar Dhanasekharan, Voyager Therapeutics

Kumar Dhanasekharan

Senior Vice President & Head of Technical Operations

Voyager Therapeutics

Lucia Faccio, Sofinnova Partners

Lucia Faccio

Partner

Sofinnova Partners

Mara Inniss, Obsidian Therapeutics

Mara Inniss

Director, Regulated Gene Editing & Gene Therapy Discover

Obsidian Therapeutics

Mark Trusheim, Tufts Medical Center

Mark Trusheim

Director - Strategic

Tufts Medical Center

Marriane Lopez, Duke University

Marriane Lopez

Senior Research Director

Duke University

Maryl Lambros, Avista Therapeutics

Maryl Lambros

Bioinformatics Scientist

Avista Therapeutics

Melissa Penn, Bayer

Melissa Penn

Director - Advocacy Relations Patient Engagement Research & Development

Bayer

Michael Rak, Carbon Biosciences

Michael Rak

Principal scientist

Carbon Biosciences

Mike Lehmicke

Senior Vice President for Science & Industry Affairs

Alliance for Regenerative Medicine

Morten Sogaard, Astellas Innovation Management

Morten Sogaard

President & Divison Head Of Gene Therapy Research & Technical Operations

Astellas Innovation Management

Niccolo Bacchi, Borea Therapeutics

Niccolo Bacchi

Chief Executive Officer

Borea Therapeutics

Olivier Danos, REGENXBIO

Olivier Danos

Chief Scientific Officer

REGENXBIO

Peter Marks, FDA

Peter Marks

Director - Center for Biologics Evaluation & Research

FDA

Priya Chockalingam, Beam Therapeutics

Priya Chockalingham

Vice President & Head of Clinical Bioanalytics & Translational Sciences

Beam Therapeutics Inc.

Rajeev Boregowda, Sanofi

Rajeev Boregowda

Associate Director

Sanofi

Ravi Iyer, Script Biosciences

Ravi Iyer

Chief Scientific Officer

Script Biosciences

Samir Koirala, Biogen

Samir Koirala

Head of Genetic, Neurodevelopmental & Epilepsy Disorders

Biogen

Sebastian Aguirre, Carbon Biosciences

Sebastian Aguirre Kozlouski

VP Platform Development

Carbon Biosciences

Sitra Tauscher W, Novartis

Sitra Tauscher-Wisniewski

VP

Novartis

Terry Cothran, Oklahoma Health Care Authority

Terry Cothran

Senior Pharmacy Director

Oklahoma Health Care Authority

Tynan Patrick, Pfizer

Tynan Patrick

Manager, Gene Therapy Purification Operations

Pfizer

Uditha DeAlwis, Sarepta

Uditha DeAlwis

Vice President - Analytical Development & Quality Control

Sarepta

Van Hoang, Spark Therapeutics

Van Hoang

Head of Analytical & QC

Spark Therapeutics

Vesselin Mitaksov, Pfizer

Vesselin Mitaksov

Associate Research Fellow

Pfizer

FULL EVENT GUIDE
REGISTER
PARTNER